RDUS - Earnings announcements

Significant Improvements Sequentially and Year-Over-Year Higher Ferrous, Nonferrous and Finished Steel Sales Volumes Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 01, 2025 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) ("Radius" or the "Company") today reported results for the third quarter of fiscal 2025 ended May 31, 2025. The Company reported a loss per share from continuing operations of $(0.59) and a net loss of $(16) million in the third quarter of fiscal 2025, a significant improvement compared to ($1.15) and ($33) million, respectively, in the second quarter of fiscal 2025. Adjusted

Ferrous and Finished Steel Sales Volumes Up Year-Over-Year Positive Operating and Free Cash Flow Radius Board Declares Quarterly Dividend PORTLAND, Ore., April 04, 2025 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) ("Radius" or the "Company") today reported results for the second quarter of fiscal 2025 ended February 28, 2025. The Company reported a loss per share from continuing operations of $(1.15) and a net loss of $(33) million in the second quarter of fiscal 2025, compared to ($1.19) and ($34) million, respectively, in the prior year second quarter. Adjusted EBITDA was approximately break-even in the second quarter of fiscal 2025, compared to $3 million in the prior ye

PORTLAND, Ore., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the first quarter of fiscal 2025 ended November 30, 2024. The Company reported a loss per share from continuing operations of $(1.30) and a net loss of $(37) million in the first quarter of fiscal 2025, compared to ($0.64) and ($18) million, respectively, in the prior year first quarter, with the difference substantially driven by a detriment on income tax in the current quarter. Adjusted EBITDA was break-even in the first quarter of fiscal 2025, compared to $1 million in the prior year first quarter. Adjusted loss per share from continuing operations was $(1.33) in the firs

PORTLAND, Ore., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its first quarter fiscal 2025 ended November 30, 2024 on Wednesday, January 8, 2025. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radius Re

Significant Sequential Improvement in Operating and Financial Performance in Q4 Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the fourth quarter and fiscal year ended August 31, 2024. The Company reported a net loss of $(16) million, or $(13) per ferrous ton, and a loss per share from continuing operations in the fourth quarter of fiscal 2024 of $(0.56), a significant improvement compared to the third quarter which included a material goodwill impairment charge. Adjusted EBITDA in the fourth quarter was $17 mi

PORTLAND, Ore., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its fourth quarter and fiscal 2024 ended August 31, 2024 on Thursday, October 24, 2024. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radiu

Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. The Company's reported and adjusted results differed significantly this quarter. Due primarily to a non-cash goodwill impairment charge reflecting the challenging market conditions for recycled metals experienced during the last year, the Company reported a loss per share from continuing operations of $(6.97) and a net loss of $(199) million in the third quarter. These results included

PORTLAND, Ore., June 18, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its third quarter fiscal 2024 ended May 31, 2024 on Tuesday, July 2, 2024. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radius Recycling, I

Nonferrous and Finished Steel Sales Volumes Up Year-Over-Year Increased Cost Reduction Target by $40 Million Radius Board Declares Quarterly Dividend PORTLAND, Ore., April 04, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the second quarter of fiscal 2024 ended February 29, 2024. The Company reported a loss per share from continuing operations of $(1.19) and a net loss of $(34) million. Adjusted EBITDA was $3 million and adjusted loss per share from continuing operations was $(1.04).   Market conditions during the second quarter remained challenging, as tight supply flows for recycled metals and unusually wet winter weathe

Nonferrous and Finished Steel Sales Volumes Up Year-over-Year Cost Reduction Target Increased PORTLAND, Ore., March 14, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today announced preliminary results for its fiscal 2024 second quarter ended February 29, 2024. Second Quarter Fiscal 2024 Expected Performance The Company anticipates: Net loss to be approximately $(35) million. Loss per share from continuing operations to be in the range of $(1.19) - $(1.24).Adjusted EBITDA to be approximately $2 million, and adjusted loss per share from continuing operations to be in the range of $(1.05) - $(1.10). Market Conditions, Prices, and Volumes. Tight supply flows for recycled

Ferrous, Nonferrous and Finished Steel Sales Volumes Up Year-Over-Year Radius Board Declares Quarterly Dividend Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ:RDUS) today reported results for the first quarter of fiscal 2024 ended November 30, 2023. The Company reported a loss per share from continuing operations of $(0.64) and a net loss of $(18) million. Adjusted loss per share from continuing operations was $(0.64) and adjusted EBITDA was $1 million. Operating performance in the first quarter reflected sequentially tighter supply flows for recycled metals, which, together with lower average net selling prices for the Company's products, resulted in a compression of

Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ:RDUS) announced that the Company will report financial results for its first quarter fiscal 2024 ended November 30, 2023 on Thursday, January 4, 2024. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Schnitzer Steel Industries, Inc. dba Radius Recycling

Strong Operating Cash Flow of $135 Million in the Fourth Quarter Radius Board Declares Quarterly Dividend Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ:RDUS) today reported results for the fourth quarter of fiscal 2023 ended August 31, 2023. The Company reported a net loss of $(26) million, or $(23) per ferrous ton, and a loss per share from continuing operations in the fourth quarter of $(0.92), all of which include non-cash goodwill and other asset impairment charges of $45 million, or $1.61 per share. Adjusted earnings per share from continuing operations were $0.47 in the fourth quarter and adjusted EBITDA was $49 million, or $44 per ferrous ton. The Company genera

Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ:RDUS) announced that the Company will report financial results for its fourth quarter and fiscal 2023 ended August 31, 2023 on Wednesday, October 25, 2023. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed under the Events Calendar on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Schnitzer Steel Indust

Transaction delivers immediate value and liquidity to Radius shareholdersResult of nine-month strategic review process by the Radius Board to maximize shareholder valuePotential per share value of $11.00, including $10.00 cash paid at closing and potential $1.00 CVRRepresents total transaction consideration of up to approximately $890 million BOSTON and CAMBRIDGE, Mass., June 23, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (NASDAQ:RDUS) today announced that it has entered into a definitive agreement to be acquired by Gurnet Point Capital ("Gurnet Point") and Patient Square Capital ("Patient Square") in a transaction valued at approximately $890 million, in

Q1 2022 TYMLOS® product net revenue of $43 million vs. $45 million in Q1 2021° Q1 results: in-line with previously guided 1H 2022 company target of $97 million° Reiterating FY 2022 TYMLOS Net Revenue guidance of $232 million° Seasonality, as previously announced: 42% of net revenue in 1H and 58% in 2H 2022° Patient Growth: average active patients on therapy increased by 4% compared to Q1 2021Productivity improvement continued: revenue per commercial headcount up 32% vs. Q1 2021TYMLOS for the Male indication: sNDA filed in Q1 2022 with launch planned for early Q1 2023Additional patent granted by USPTO for TYMLOS: extending exclusivity to January 10, 2040Elacestrant: on schedule for US regulat

BOSTON, April 25, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (NASDAQ:RDUS) announced today that it will release its first quarter 2022 financial results on Thursday, May 5, 2022. The Company will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the results and provide a business update. Conference Call Information:Domestic Dial-In Number: 1 (866) 323-7965International Dial-In Number: 1 (346) 406-0961Conference ID: 5844208Webcast Link: https://edge.media-server.com/mmc/p/nmcknbsv A replay of the conference call will be available on May 5th at 11:30 a.m. ET. A live audio webcast of the call will be archived on the Company's website for

Focus: RAD011, an investigational synthetic cannabidiol oral solutionWebcast details: 10:00am to 12:00pm for current or prospective investors and sell side analystsObjectives: asset overview, science, regulatory, and clinical translation progress since acquisition BOSTON, April 05, 2022 (GLOBE NEWSWIRE) -- Today, Radius Health, Inc. ("Radius" or the "Company") (NASDAQ:RDUS) will host its Neuroscience R&D webcast to discuss RAD011, our investigational synthetic cannabidiol oral solution with potential utilization in multiple neuro-endocrine, neurodevelopmental, or neuropsychiatric disease areas. The webcast will be held from 10:00am to 12:00pm ET allowing for 1.5 hours of presentations an

Focus: RAD011, our investigational synthetic cannabidiol oral solutionBroad market interest in the underlying science, data, and clinical translation of the assetGoal: provide foundational review of the asset and progress since acquisition in December, 2020 BOSTON, March 03, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (NASDAQ:RDUS) today announced details of its virtual R&D Webcast focused on RAD011. RAD011 is the Company's investigational synthetic cannabidiol oral solution which has potential utilization in multiple orphan diseases. As previously reported, we are currently examining three orphan indications: Prader-Willi syndrome (PWS), with the goal of

Q4 2021 TYMLOS® net revenue of $65 million vs. $60 million in Q4 2020, up 9%This is a record quarter – over 18 quarters – since the launch in May 2017FY 2021 TYMLOS Net Revenue of $219 vs. $208 million in FY 2020, up 5%Net Loss reduced by ~36%: ($70) million FY 2021 vs ($109) million FY 2020Adjusted EBITDA (Non-GAAP) loss reduced by ~56%: ($24) million FY 2021 vs. ($54) million FY 2020FY 2022 financial objectives: $232 million TYMLOS Net RevenueIncorporate seasonality of Net Revenue: ~42% in 1H and ~58% in 2H 2022($5) to $5 million Net Loss$35 to $45 million Company Adjusted EBITDA (Non-GAAP) FY 2022 asset objectives: File abaloparatide male sNDA in Q1 2022 and elacestrant mon

BOSTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (NASDAQ:RDUS) announced today that it will release its fourth quarter and full year 2021 financial results on Thursday, February 24, 2022. The Company will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the results and provide a company update. Conference Call Information:Domestic Dial-In Number: 1 (866) 323-7965International Dial-In Number: 1 (346) 406-0961Conference ID: 7696052Webcast Link: https://edge.media-server.com/mmc/p/syvxxq83 A replay of the conference call will be available on February 24 at 11:30 a.m. ET through March 3. A live audio webcast of the call will be archived on the Company's w

BOSTON, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (NASDAQ:RDUS) announced it will host a conference call today, Wednesday, December 8, 2021, at 4:00 p.m. ET to cover the below: Discuss topline results from the wearABLe Phase 3 trialReview data presented at the San Antonio Breast Cancer Symposium from the EMERALD Phase 3 trial Conference Call Information:Domestic Dial-In Number: 1 (866) 323-7965International Dial-In Number: 1 (346) 406-0961Conference ID: 7691981 A replay of the conference call will be available on December 8 at 7:00 p.m. ET and a live audio webcast of the call will be archived on the Company's website for ninety days. To access the

TYMLOS® Q3, 2021 net revenue: $57 million, +13% vs. Q3, 2020Added 4,461 new patients on TYMLOS in Q3, 2021, +10% vs. Q3, 2020Adjusted EBITDA of ($11) million vs. $9 million in Q3, 2020 which included elacestrant license revenueATOM Pivotal Study evaluating abaloparatide-SC for use in males with osteoporosis met primary and key secondary endpoints; sNDA filing is expected Q1, 2022Resubmitted abaloparatide-SC to the European Medicines Agency (EMA) on November 4, 2021wearABLe Pivotal Study (abaloparatide-TD) topline readout remains on track for Q4, 2021EMERALD Pivotal Study evaluating elacestrant in breast cancer was positive as a monotherapy vs. standard of care in patients with ER+/HER2- mBC,

BOSTON, Oct. 21, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline yesterday, Oct. 20, by Radius Health, Inc. (NASDAQ:RDUS), please note that the dial-in numbers were listed incorrectly. The correct dial-in numbers are (866) 323-7965 for domestic calls and (346) 406-0961 for international calls. The conference ID remains the same, 9322858. The corrected release appears below: Radius Health, Inc. (NASDAQ:RDUS) announced today that it will release its third quarter financial results on Monday, November 8, 2021. The Company will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the results and provide a company update. Conference Call Information:Do

BOSTON, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (NASDAQ:RDUS) announced today that it will release its third quarter financial results on Monday, November 8, 2021. The Company will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the results and provide a company update. Conference Call Information:Domestic Dial-In Number: 1 (855) 404-2458International Dial-In Number: 1 (430) 775-1272Conference ID: 9322858Webcast Link: https://edge.media-server.com/mmc/p/945gpbaj A replay of the conference call will be available on November 8 at 11:30 a.m. ET and a live audio webcast of the call will be archived on the Company's website for ninety days. To access the

Repositioned the Company to create meaningful P+L operating leverageDramatic improvement in Adj. EBITDA performance: ($6) million in Q2, 2021 vs. ($29) million in Q2, 2020FY 2021 guidance: reiterate Adj. EBITDA of $10 million while reducing TYMLOS revenue from $250 to $240 millionTYMLOS Q2, 2021 net revenue: $52 million, +3% year-over-yearTYMLOS new patient growth: Q2, 2021, up 40+% vs. Q2, 2020 and 1H, 2021 up 18% vs. 1H, 2020Successful elacestrant BE study: established bioequivalence between clinical and commercial supply BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (NASDAQ:RDUS), today reported its financial results for the second